05Dec 2022
PPI‐induced changes in plasma metabolite levels influence total hip bone mineral density in a UK cohort

PPI‐induced changes in plasma metabolite levels influence total hip bone mineral density in a UK cohort

Proton pump inhibitors (PPIs) are the most used drugs in the UK. PPI use has been associated with decreased bone mineral density (BMD) and increased fracture risk, although these results have been inconsistent. This study hypothesised that PPI could modulate BMD by altering gut and host systemic metabolic environments. Using data from more than 5,000 British male and female individuals, we confirmed that PPI use is associated with decreased lumbar spine and total hip BMD. However, this effect was not mediated through the gut microbiome. We suggest that PPI use may influence total hip BMD, directly and indirectly, via plasma metabolites involved in the sex hormone pathway.

  • #orthopaedics

Like

Save

Share